Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eton Pharmaceuticals (ETON) Treasury Shares (2018 - 2024)

Eton Pharmaceuticals' Treasury Shares history spans 5 years, with the latest figure at $226068.0 for Q4 2024.

  • On a quarterly basis, Treasury Shares fell 17.55% to $226068.0 in Q4 2024 year-over-year; TTM through Dec 2024 was $226068.0, a 17.55% decrease, with the full-year FY2024 number at $226068.0, down 17.55% from a year prior.
  • Treasury Shares hit $226068.0 in Q4 2024 for Eton Pharmaceuticals, down from $274204.0 in the prior quarter.
  • Over the last five years, Treasury Shares for ETON hit a ceiling of $369606.0 in Q3 2022 and a floor of $7595.0 in Q4 2020.
  • Historically, Treasury Shares has averaged $249415.8 across 4 years, with a median of $274204.0 in 2023.
  • Biggest five-year swings in Treasury Shares: fell 25.81% in 2023 and later dropped 17.55% in 2024.
  • Tracing ETON's Treasury Shares over 4 years: stood at $7595.0 in 2020, then surged by 4766.44% to $369606.0 in 2022, then fell by 25.81% to $274204.0 in 2023, then dropped by 17.55% to $226068.0 in 2024.
  • Business Quant data shows Treasury Shares for ETON at $226068.0 in Q4 2024, $274204.0 in Q4 2023, and $369606.0 in Q4 2022.